Prognostic impact of perioperative serum CA 19-9 levels in patients with resectable pancreatic cancer.
Kondo N, Murakami Y, Uemura K, Hayashidani Y, Sudo T, Hashimoto Y, Nakashima A, Sakabe R, Shigemoto N, Kato Y, Ohge H, Sueda T.
Kondo N, et al. Among authors: nakashima a.
Ann Surg Oncol. 2010 Sep;17(9):2321-9. doi: 10.1245/s10434-010-1033-0. Epub 2010 Mar 25.
Ann Surg Oncol. 2010.
PMID: 20336387
Clinical Trial.